Lei Huo Selected Research

Breast Neoplasms (Breast Cancer)

2/2024	Comparison of PD-L1 (22C3) Expression in Paired Primary and Metastatic Breast Carcinoma.
12/2023	Correlation of HER2 Protein Level With mRNA Level Quantified by RNAscope in Breast Cancer.
10/2023	Cytosolic DNA accumulation promotes breast cancer immunogenicity via a STING-independent pathway.
9/2023	Discordance of Oncotype DX scores in synchronous bilateral and unilateral multifocal breast cancers.
8/2023	Nuclear staining for pan-Trk by immunohistochemistry is highly specific for secretory carcinoma of breast: pan-Trk in various subtypes of breast carcinoma.
4/2023	Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma.
4/2023	TRPS1 and GATA3 Expression in Invasive Breast Carcinoma With Apocrine Differentiation.
1/2023	Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer.
1/2023	PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens.
1/2023	Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lei Huo Research Topics

Disease

56	Neoplasms (Cancer) 03/2024 - 10/2002
37	Breast Neoplasms (Breast Cancer) 02/2024 - 03/2009
19	Triple Negative Breast Neoplasms 01/2024 - 01/2013
12	Glioma (Gliomas) 01/2021 - 09/2008
10	Neoplasm Metastasis (Metastasis) 01/2023 - 03/2009
9	Inflammatory Breast Neoplasms 02/2018 - 12/2011
6	Pathologic Complete Response 01/2023 - 05/2019
5	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 01/2020
5	Carcinoma (Carcinomatosis) 08/2023 - 10/2011
4	Cholangiocarcinoma 12/2023 - 01/2020
3	Wounds and Injuries (Trauma) 05/2024 - 06/2019
3	Brain Neoplasms (Brain Tumor) 12/2020 - 02/2015
3	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 06/2015
2	Hypoxia (Hypoxemia) 05/2024 - 09/2012
2	Osteonecrosis (Kienbock's Disease) 01/2021 - 10/2015
2	Hemorrhage 01/2020 - 01/2019
2	Disease Progression 11/2016 - 06/2014
2	Brain Edema (Cerebral Edema) 09/2012 - 09/2012
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 09/2012 - 09/2012
1	Acute Kidney Injury (Acute Renal Failure) 05/2024
1	Chronic Renal Insufficiency 05/2024
1	Bites and Stings (Sting) 10/2023
1	Acinar Cell Carcinoma 08/2023
1	Adenoid Cystic Carcinoma (Cylindroma) 08/2023
1	Residual Neoplasm 01/2023
1	Adenocarcinoma of Lung 01/2023
1	Carcinosarcoma 10/2021
1	Pneumonia (Pneumonitis) 01/2020

Drug/Important Bio-Agent (IBA)

18	Estrogen ReceptorsIBA 09/2023 - 03/2009
14	Biomarkers (Surrogate Marker)IBA 12/2023 - 04/2015
10	Proteins (Proteins, Gene)FDA Link 05/2024 - 03/2005
8	Progesterone Receptors (Progesterone Receptor)IBA 09/2023 - 04/2011
7	Messenger RNA (mRNA)IBA 05/2024 - 03/2012
6	Androgen Receptors (Androgen Receptor)IBA 03/2024 - 06/2014
6	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2015
5	Temozolomide (Temodar)FDA LinkGeneric 01/2019 - 07/2012
5	Hormones (Hormone)IBA 08/2017 - 01/2015
4	Phenobarbital (Luminal)FDA Link 03/2024 - 05/2019
4	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2023
4	human ERBB2 proteinIBA 04/2023 - 06/2014
3	B7-H1 AntigenIBA 10/2021 - 02/2018
3	Keratins (Keratin)IBA 01/2017 - 08/2005
3	Monoclonal AntibodiesIBA 11/2015 - 03/2005
2	Transcription Factors (Transcription Factor)IBA 05/2024 - 08/2017
2	N-acetyltalosaminuronic acid (NAT)IBA 03/2024 - 10/2021
2	RNA (Ribonucleic Acid)IBA 12/2023 - 10/2021
2	AntigensIBA 10/2023 - 11/2015
2	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2017
2	CateninsIBA 01/2019 - 01/2017
2	Diphosphonates (Bisphosphonates)IBA 01/2019 - 10/2015
2	GlucocorticoidsIBA 07/2018 - 04/2016
2	ErbB Receptors (EGF Receptor)IBA 10/2016 - 09/2016
2	Cadherins (E-Cadherin)IBA 04/2016 - 02/2015
2	Mammaglobin AIBA 08/2015 - 01/2013
2	Enhancer of Zeste Homolog 2 ProteinIBA 07/2014 - 12/2011
2	Polycomb-Group ProteinsIBA 07/2014 - 12/2011
1	Calcium-Binding ProteinsIBA 05/2024
1	trastuzumab deruxtecanIBA 12/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2023
1	Alkaline PhosphataseIBA 12/2023
1	AlbuminsIBA 12/2023
1	CarbohydratesIBA 10/2023
1	lestaurtinibIBA 10/2023
1	Single-Stranded DNA (DNA, Single Stranded)IBA 10/2023
1	AnthracyclinesIBA 06/2023
1	130-nm albumin-bound paclitaxelIBA 06/2023
1	atezolizumabIBA 06/2023
1	Poly Adenosine Diphosphate RiboseIBA 04/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2023
1	N-myc downstream-regulated gene 1 proteinIBA 11/2022
1	Adenosine Monophosphate (AMP)IBA 09/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Histones (Histone)IBA 10/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2021
1	Folate Receptor 1IBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	mirvetuximab soravtansineIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	ST6GalNAc V brain-specific GD1alpha synthaseIBA 12/2020
1	5' Untranslated Regions (5' UTR)IBA 12/2020
1	6-methyladenineIBA 12/2020
1	Small Nucleolar RNA (snoRNA)IBA 12/2020
1	CarcinogensIBA 12/2020
1	Capsules (Microcapsules)IBA 10/2020
1	NivolumabIBA 01/2020
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2020

Therapy/Procedure

23	Therapeutics 02/2024 - 03/2012
17	Neoadjuvant Therapy 03/2024 - 04/2015
7	Drug Therapy (Chemotherapy) 06/2023 - 06/2010
6	Radiotherapy 01/2021 - 07/2012
4	Hepatectomy 01/2022 - 01/2020
3	Immunotherapy 02/2024 - 01/2020
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 10/2023 - 01/2016
3	Chemoradiotherapy 12/2019 - 07/2012
3	Craniotomy 04/2009 - 10/2002
1	Tooth Extraction (Tooth Extractions) 01/2021
1	Sutures (Suture) 01/2021